Advancing personalized care in hemophilia A: ten years’ experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method
Erik Berntorp,1 Gerald Spotts,2 Lisa Patrone,2 Bruce M Ewenstein2 1Malmö Centre for Thrombosis and Haemostasis, Lund University, Skåne University Hospital, Malmö, Sweden; 2Baxter Healthcare Corporation, Westlake Village, CA, USA Abstract: Detailed analysis of data from...
Guardado en:
Autores principales: | Berntorp E, Spotts G, Patrone L, Ewenstein BM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a55139c3d3774a4ca791671300ce97e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
por: Steven Pipe
Publicado: (2009) -
Recent Advances in the Treatment of Hemophilia: A Review
por: Marchesini E, et al.
Publicado: (2021) -
Advances in the preparations and applications of nanochitins
por: Luca Serventi, et al.
Publicado: (2021) -
The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
por: Haowei (Linda) Sun, et al.
Publicado: (2021) -
Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy
por: Xue Shen, et al.
Publicado: (2021)